Physician profile
Chandrahas Agarwal
NPI 1528014172
$1,506.29
in general payments reported to CMS, 2019-2025
20 companies · $70.15 in 2025
The $70.15 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.22 · 2020: $392 · 2021: $300 · 2022: $223 · 2023: $334 · 2024: $129 · 2025: $70.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $260.25 | 2020 | |
| Novartis Pharmaceuticals Corporation | $167.84 | 2019-2024 | |
| Abiomed | $148.17 | 2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.34 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $127.72 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $114.54 | 2019-2025 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $108.05 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Medtronic, INC. | $53.66 | 2021 | |
| Edwards Lifesciences Corporation | $48.96 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi-Aventis U.S. LLC | $44.78 | 2020-2021 | |
| Boston Scientific Corporation | $44.69 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $28.06 | 2024 | Repatha |
| Pfizer INC. | $22.23 | 2023 | |
| Cardiovascular Systems INC. | $21.99 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.68 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $19.51 | 2023 | Inpefa |
| Infobionic, INC | $17.60 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.03 | 2022 | |
| Biotronik INC. | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandrahas Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.